Raising revenue guidance typically signals to investors that a company is performing better than previously expected, which can lead to increased investor confidence and a rise in stock price. Given that this news directly pertains to Twist Bioscience's financial outlook, it is highly relevant and important for investors, warranting a high confidence score in the positive short-term impact on the stock.